This is evidenced by the lack of ZEB1 alteration upon p65 silencing, suggesting a distinct, direct regulatory role for KPC1 in controlling melanoma plasticity via ZEB1 that is separate from its impact on NF-κB signaling. The gene discussed is NFKB1; the disease is melanoma.